NON-ST Segment Elevation Acute Coronary Syndrome In Patients With Renal Dysfunction: Benefit Of Low Molecular Weight Heparin With Glycoprotein IIb/IIIa Inhibitors on Outcome Compared To Unfractionated Heparin With Glycoprotein IIb/IIIa Inhibitors
MEDHET HASSAN MOHAMED;
Abstract
Ischemic heart disease represents a significant public health burden. UA/NSTEMI is the most common diagnosis
The use of low molecular weight heparin (LMWH) remains disproportionately low especially in the patients with renal impairment GP IIb/IIIa inhib
The use of low molecular weight heparin (LMWH) remains disproportionately low especially in the patients with renal impairment GP IIb/IIIa inhib
Other data
| Title | NON-ST Segment Elevation Acute Coronary Syndrome In Patients With Renal Dysfunction: Benefit Of Low Molecular Weight Heparin With Glycoprotein IIb/IIIa Inhibitors on Outcome Compared To Unfractionated Heparin With Glycoprotein IIb/IIIa Inhibitors | Authors | MEDHET HASSAN MOHAMED | Keywords | NON-ST Segment Elevation Acute Coronary Syndrome In Patients With Renal Dysfunction: Benefit Of Low Molecular Weight Heparin With Glycoprotein IIb/IIIa Inhibitors on Outcome Compared To Unfractionated Heparin With Glycoprotein IIb/IIIa Inhibitors | Issue Date | 2007 | Description | Ischemic heart disease represents a significant public health burden. UA/NSTEMI is the most common diagnosis The use of low molecular weight heparin (LMWH) remains disproportionately low especially in the patients with renal impairment GP IIb/IIIa inhib |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 91804Untitled.pdf | 322.29 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.